Austin Larson
Concepts (354)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 12 | 2024 | 229 | 2.040 |
Why?
| | Intellectual Disability | 8 | 2024 | 179 | 1.760 |
Why?
| | Congenital Disorders of Glycosylation | 9 | 2026 | 17 | 1.670 |
Why?
| | Abnormalities, Multiple | 7 | 2024 | 199 | 1.380 |
Why?
| | Mutation | 18 | 2026 | 4090 | 1.140 |
Why?
| | Phenotype | 23 | 2026 | 3170 | 0.950 |
Why?
| | Bone Diseases, Developmental | 2 | 2024 | 16 | 0.910 |
Why?
| | Mitochondrial Diseases | 5 | 2026 | 92 | 0.900 |
Why?
| | Mitochondrial Encephalomyopathies | 2 | 2020 | 9 | 0.780 |
Why?
| | Mitochondria | 7 | 2026 | 992 | 0.780 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 2 | 2020 | 23 | 0.690 |
Why?
| | Diet, Ketogenic | 3 | 2021 | 39 | 0.670 |
Why?
| | Xanthomatosis, Cerebrotendinous | 3 | 2025 | 5 | 0.640 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 14 | 0.620 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2019 | 6 | 0.610 |
Why?
| | Gray Matter | 1 | 2019 | 92 | 0.570 |
Why?
| | Dystroglycans | 1 | 2018 | 5 | 0.560 |
Why?
| | Qb-SNARE Proteins | 1 | 2018 | 7 | 0.560 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 28 | 0.550 |
Why?
| | Infant | 25 | 2025 | 10089 | 0.550 |
Why?
| | Multiple Carboxylase Deficiency | 1 | 2018 | 1 | 0.540 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 85 | 0.520 |
Why?
| | Glycosylation | 9 | 2026 | 173 | 0.520 |
Why?
| | Phosphotransferases (Phosphomutases) | 4 | 2025 | 6 | 0.510 |
Why?
| | Child, Preschool | 25 | 2026 | 11866 | 0.450 |
Why?
| | Acidosis, Lactic | 3 | 2024 | 46 | 0.450 |
Why?
| | Hypopituitarism | 1 | 2015 | 16 | 0.440 |
Why?
| | Mitochondrial Proteins | 3 | 2026 | 263 | 0.440 |
Why?
| | Cardiomyopathies | 3 | 2024 | 335 | 0.430 |
Why?
| | Developmental Disabilities | 3 | 2024 | 281 | 0.420 |
Why?
| | Adrenal Insufficiency | 3 | 2021 | 31 | 0.420 |
Why?
| | Genetic Association Studies | 5 | 2025 | 371 | 0.410 |
Why?
| | Seizures | 5 | 2023 | 485 | 0.400 |
Why?
| | Prilocaine | 1 | 2013 | 5 | 0.390 |
Why?
| | Methemoglobinemia | 1 | 2013 | 13 | 0.390 |
Why?
| | Cephalometry | 1 | 2013 | 30 | 0.380 |
Why?
| | Dystocia | 1 | 2013 | 12 | 0.380 |
Why?
| | Humans | 68 | 2026 | 145750 | 0.380 |
Why?
| | Sexual Development | 1 | 2012 | 17 | 0.380 |
Why?
| | Female | 46 | 2026 | 79025 | 0.380 |
Why?
| | Fetal Macrosomia | 1 | 2013 | 63 | 0.370 |
Why?
| | Lidocaine | 1 | 2013 | 55 | 0.370 |
Why?
| | Liver Transplantation | 1 | 2020 | 826 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 6 | 2020 | 3915 | 0.370 |
Why?
| | Shoulder | 1 | 2013 | 105 | 0.370 |
Why?
| | Child | 31 | 2026 | 22738 | 0.360 |
Why?
| | Anesthetics, Local | 1 | 2013 | 104 | 0.360 |
Why?
| | Membrane Transport Proteins | 2 | 2026 | 154 | 0.350 |
Why?
| | Male | 43 | 2026 | 72992 | 0.340 |
Why?
| | Carnitine | 2 | 2025 | 91 | 0.340 |
Why?
| | DNA, Mitochondrial | 2 | 2024 | 211 | 0.340 |
Why?
| | Adolescent | 21 | 2026 | 22569 | 0.330 |
Why?
| | Infant, Newborn | 12 | 2026 | 6464 | 0.310 |
Why?
| | Heterozygote | 6 | 2024 | 314 | 0.290 |
Why?
| | Chenodeoxycholic Acid | 2 | 2025 | 12 | 0.280 |
Why?
| | Cholestanol | 2 | 2025 | 4 | 0.270 |
Why?
| | Transcription Factors | 4 | 2022 | 1736 | 0.260 |
Why?
| | Epilepsy | 3 | 2023 | 390 | 0.260 |
Why?
| | Genetic Testing | 4 | 2023 | 483 | 0.260 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 2019 | 8 | 0.260 |
Why?
| | Genetic Variation | 3 | 2021 | 976 | 0.250 |
Why?
| | Biomarkers | 8 | 2026 | 4302 | 0.250 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 592 | 0.250 |
Why?
| | Fibroblasts | 6 | 2026 | 1027 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 4 | 2019 | 2399 | 0.240 |
Why?
| | Epidermolysis Bullosa Simplex | 1 | 2026 | 14 | 0.240 |
Why?
| | Photophobia | 1 | 2026 | 13 | 0.240 |
Why?
| | Fucose | 1 | 2026 | 7 | 0.230 |
Why?
| | Ichthyosis | 1 | 2026 | 15 | 0.230 |
Why?
| | Alopecia | 1 | 2026 | 37 | 0.230 |
Why?
| | MELAS Syndrome | 1 | 2025 | 5 | 0.230 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2026 | 56 | 0.230 |
Why?
| | Nuclear Proteins | 2 | 2022 | 740 | 0.230 |
Why?
| | Receptors, Virus | 1 | 2026 | 95 | 0.230 |
Why?
| | Rhodanine | 2 | 2023 | 2 | 0.230 |
Why?
| | Thiazolidines | 2 | 2023 | 13 | 0.230 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2025 | 12 | 0.220 |
Why?
| | Carrier Proteins | 2 | 2019 | 729 | 0.220 |
Why?
| | Young Adult | 13 | 2026 | 14250 | 0.220 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 423 | 0.220 |
Why?
| | Collagen Type VII | 1 | 2025 | 27 | 0.220 |
Why?
| | Nervous System Malformations | 2 | 2022 | 46 | 0.220 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 7 | 0.220 |
Why?
| | Actins | 2 | 2019 | 427 | 0.210 |
Why?
| | Zebrafish | 3 | 2026 | 532 | 0.210 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2025 | 41 | 0.210 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 42 | 0.210 |
Why?
| | Metabolism, Inborn Errors | 2 | 2021 | 42 | 0.210 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.210 |
Why?
| | Loss of Function Mutation | 2 | 2021 | 45 | 0.210 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.210 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 31 | 0.210 |
Why?
| | Sotos Syndrome | 1 | 2024 | 2 | 0.210 |
Why?
| | Septo-Optic Dysplasia | 1 | 2024 | 5 | 0.200 |
Why?
| | Adult | 20 | 2026 | 40867 | 0.200 |
Why?
| | Megalencephaly | 1 | 2024 | 20 | 0.200 |
Why?
| | Chromosome Disorders | 1 | 2023 | 47 | 0.200 |
Why?
| | Aldehyde Reductase | 1 | 2023 | 31 | 0.190 |
Why?
| | Niacinamide | 1 | 2024 | 104 | 0.190 |
Why?
| | Craniofacial Abnormalities | 1 | 2024 | 78 | 0.190 |
Why?
| | Autistic Disorder | 2 | 2023 | 219 | 0.190 |
Why?
| | Chromosome Deletion | 2 | 2023 | 126 | 0.190 |
Why?
| | Bile Acids and Salts | 1 | 2024 | 163 | 0.190 |
Why?
| | Hematologic Diseases | 1 | 2023 | 66 | 0.180 |
Why?
| | Cerebellar Diseases | 1 | 2022 | 27 | 0.180 |
Why?
| | De Lange Syndrome | 1 | 2022 | 2 | 0.180 |
Why?
| | Phosphoproteins | 2 | 2021 | 337 | 0.180 |
Why?
| | RNA, Transfer | 2 | 2020 | 143 | 0.180 |
Why?
| | Amino Acid Substitution | 2 | 2020 | 302 | 0.180 |
Why?
| | Vestibular Diseases | 1 | 2023 | 57 | 0.180 |
Why?
| | Transposases | 1 | 2022 | 18 | 0.180 |
Why?
| | Sorbitol | 1 | 2021 | 13 | 0.180 |
Why?
| | Dwarfism | 1 | 2021 | 14 | 0.180 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2020 | 534 | 0.170 |
Why?
| | Wolf-Hirschhorn Syndrome | 1 | 2021 | 2 | 0.170 |
Why?
| | Metabolism | 1 | 2021 | 44 | 0.170 |
Why?
| | Methionine | 1 | 2021 | 161 | 0.160 |
Why?
| | Vitamin B 12 | 1 | 2021 | 135 | 0.160 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2021 | 130 | 0.160 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2020 | 8 | 0.160 |
Why?
| | Receptors, CCR4 | 1 | 2020 | 24 | 0.160 |
Why?
| | Aldehyde-Lyases | 1 | 2020 | 3 | 0.160 |
Why?
| | Nephrosis | 1 | 2020 | 6 | 0.160 |
Why?
| | Drosophila Proteins | 1 | 2022 | 214 | 0.160 |
Why?
| | Vitamin B 6 | 1 | 2020 | 11 | 0.160 |
Why?
| | Prenatal Care | 1 | 2023 | 309 | 0.160 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 2021 | 39 | 0.160 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 24 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 143 | 0.160 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 10 | 0.160 |
Why?
| | Mucolipidoses | 1 | 2020 | 9 | 0.160 |
Why?
| | Quinone Reductases | 1 | 2020 | 14 | 0.160 |
Why?
| | Dietary Supplements | 2 | 2026 | 584 | 0.160 |
Why?
| | Myotonin-Protein Kinase | 1 | 2020 | 2 | 0.160 |
Why?
| | Leigh Disease | 1 | 2020 | 22 | 0.160 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 778 | 0.160 |
Why?
| | Thymidine | 1 | 2020 | 60 | 0.160 |
Why?
| | ATP-Dependent Proteases | 1 | 2020 | 2 | 0.160 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2020 | 2 | 0.160 |
Why?
| | Muscular Diseases | 1 | 2020 | 109 | 0.160 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 287 | 0.160 |
Why?
| | Lymphopenia | 1 | 2020 | 62 | 0.150 |
Why?
| | Tyrosine | 1 | 2020 | 217 | 0.150 |
Why?
| | Tumor Suppressor Proteins | 1 | 2022 | 322 | 0.150 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 5 | 0.150 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 30 | 0.150 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 47 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2026 | 935 | 0.150 |
Why?
| | Membrane Proteins | 2 | 2023 | 1166 | 0.150 |
Why?
| | Mutagenesis, Insertional | 1 | 2019 | 68 | 0.150 |
Why?
| | Albinism | 1 | 2019 | 3 | 0.150 |
Why?
| | Lysosomal Storage Diseases | 1 | 2019 | 5 | 0.150 |
Why?
| | Acids | 1 | 2019 | 17 | 0.150 |
Why?
| | Retrospective Studies | 8 | 2026 | 17322 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2022 | 741 | 0.150 |
Why?
| | Chloride Channels | 1 | 2019 | 33 | 0.150 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2021 | 141 | 0.150 |
Why?
| | Oligonucleotides, Antisense | 1 | 2019 | 120 | 0.150 |
Why?
| | Proteolysis | 1 | 2020 | 172 | 0.140 |
Why?
| | Scoliosis | 1 | 2021 | 221 | 0.140 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 54 | 0.140 |
Why?
| | Galactosyltransferases | 1 | 2018 | 12 | 0.140 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 134 | 0.140 |
Why?
| | Leukoencephalopathies | 1 | 2018 | 24 | 0.140 |
Why?
| | Rare Diseases | 1 | 2019 | 116 | 0.140 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2018 | 16 | 0.140 |
Why?
| | Bronchiectasis | 1 | 2020 | 115 | 0.140 |
Why?
| | Lysosomes | 1 | 2019 | 131 | 0.140 |
Why?
| | Spasms, Infantile | 1 | 2020 | 138 | 0.140 |
Why?
| | Arginine | 1 | 2019 | 264 | 0.140 |
Why?
| | Fetus | 1 | 2023 | 804 | 0.140 |
Why?
| | Gene Expression | 2 | 2020 | 1478 | 0.140 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2018 | 31 | 0.140 |
Why?
| | Metalloendopeptidases | 1 | 2018 | 63 | 0.140 |
Why?
| | Nerve Degeneration | 1 | 2018 | 49 | 0.140 |
Why?
| | Ubiquinone | 1 | 2018 | 35 | 0.140 |
Why?
| | Enzyme Inhibitors | 1 | 2021 | 821 | 0.130 |
Why?
| | Trachea | 1 | 2020 | 258 | 0.130 |
Why?
| | Molecular Chaperones | 1 | 2020 | 199 | 0.130 |
Why?
| | Phenylalanine-tRNA Ligase | 1 | 2017 | 2 | 0.130 |
Why?
| | Ataxia | 1 | 2018 | 69 | 0.130 |
Why?
| | Nephrotic Syndrome | 1 | 2018 | 43 | 0.130 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2017 | 12 | 0.130 |
Why?
| | Cohort Studies | 4 | 2026 | 6032 | 0.130 |
Why?
| | Muscle Weakness | 1 | 2018 | 92 | 0.130 |
Why?
| | Catalytic Domain | 1 | 2018 | 234 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2020 | 699 | 0.130 |
Why?
| | Cellular Senescence | 1 | 2019 | 226 | 0.120 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 156 | 0.120 |
Why?
| | Urinary Bladder | 2 | 2019 | 196 | 0.120 |
Why?
| | Colon | 2 | 2019 | 309 | 0.120 |
Why?
| | Diabetes Insipidus | 1 | 2015 | 6 | 0.110 |
Why?
| | Holoprosencephaly | 1 | 2015 | 8 | 0.110 |
Why?
| | Pregnancy | 5 | 2023 | 7215 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 461 | 0.110 |
Why?
| | Cholestanetriol 26-Monooxygenase | 2 | 2025 | 7 | 0.110 |
Why?
| | Human Growth Hormone | 1 | 2015 | 47 | 0.110 |
Why?
| | Thyrotropin | 1 | 2015 | 120 | 0.110 |
Why?
| | Hypogonadism | 1 | 2015 | 93 | 0.100 |
Why?
| | Brain | 4 | 2020 | 2969 | 0.100 |
Why?
| | Muscle, Skeletal | 3 | 2020 | 1791 | 0.100 |
Why?
| | Histones | 1 | 2019 | 666 | 0.100 |
Why?
| | Introns | 2 | 2025 | 256 | 0.100 |
Why?
| | RNA | 1 | 2020 | 912 | 0.100 |
Why?
| | Mutation, Missense | 3 | 2021 | 335 | 0.100 |
Why?
| | Cephalopelvic Disproportion | 1 | 2013 | 2 | 0.100 |
Why?
| | Vacuum Extraction, Obstetrical | 1 | 2013 | 4 | 0.100 |
Why?
| | Port-Wine Stain | 1 | 2013 | 4 | 0.100 |
Why?
| | Rhode Island | 1 | 2013 | 31 | 0.100 |
Why?
| | Quality of Life | 1 | 2025 | 3210 | 0.090 |
Why?
| | Brachial Plexus | 1 | 2013 | 34 | 0.090 |
Why?
| | WT1 Proteins | 1 | 2012 | 12 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2181 | 0.090 |
Why?
| | Administration, Topical | 1 | 2013 | 155 | 0.090 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 27 | 0.090 |
Why?
| | Homozygote | 2 | 2025 | 199 | 0.090 |
Why?
| | RNA Splicing Factors | 1 | 2012 | 66 | 0.090 |
Why?
| | Middle Aged | 8 | 2026 | 36297 | 0.090 |
Why?
| | Drosophila | 2 | 2023 | 166 | 0.080 |
Why?
| | Pedigree | 2 | 2026 | 515 | 0.080 |
Why?
| | DNA-Binding Proteins | 2 | 2022 | 1482 | 0.080 |
Why?
| | Case-Control Studies | 2 | 2022 | 3634 | 0.080 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 61 | 0.080 |
Why?
| | Syndrome | 2 | 2022 | 381 | 0.080 |
Why?
| | Alleles | 2 | 2026 | 896 | 0.080 |
Why?
| | Haploinsufficiency | 2 | 2020 | 54 | 0.080 |
Why?
| | Urban Population | 1 | 2013 | 494 | 0.080 |
Why?
| | DNA Mutational Analysis | 2 | 2021 | 410 | 0.070 |
Why?
| | Oxidative Phosphorylation | 2 | 2020 | 209 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2013 | 306 | 0.070 |
Why?
| | Electron Transport | 2 | 2020 | 110 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1512 | 0.070 |
Why?
| | Skin | 2 | 2026 | 754 | 0.070 |
Why?
| | Genotype | 2 | 2026 | 1857 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2022 | 630 | 0.070 |
Why?
| | Prospective Studies | 3 | 2025 | 8075 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 910 | 0.060 |
Why?
| | Proteomics | 2 | 2024 | 1188 | 0.060 |
Why?
| | Mitochondrial Myopathies | 1 | 2026 | 10 | 0.060 |
Why?
| | Animals | 6 | 2026 | 38100 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2026 | 100 | 0.060 |
Why?
| | Cholestenones | 1 | 2025 | 1 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2021 | 1137 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1082 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.050 |
Why?
| | Genes, Recessive | 1 | 2025 | 78 | 0.050 |
Why?
| | Exome | 2 | 2017 | 229 | 0.050 |
Why?
| | DNA Helicases | 1 | 2026 | 136 | 0.050 |
Why?
| | Cholestanols | 1 | 2024 | 1 | 0.050 |
Why?
| | NFI Transcription Factors | 1 | 2024 | 7 | 0.050 |
Why?
| | Dried Blood Spot Testing | 1 | 2025 | 126 | 0.050 |
Why?
| | Age of Onset | 1 | 2026 | 557 | 0.050 |
Why?
| | Aged | 4 | 2026 | 26212 | 0.050 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2023 | 36 | 0.050 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2023 | 24 | 0.050 |
Why?
| | Mannose | 1 | 2023 | 23 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 195 | 0.050 |
Why?
| | Goals | 1 | 2025 | 185 | 0.050 |
Why?
| | Fatigue | 1 | 2025 | 365 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2805 | 0.050 |
Why?
| | Histone Demethylases | 1 | 2023 | 38 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 396 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5921 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 610 | 0.050 |
Why?
| | Exons | 1 | 2024 | 364 | 0.050 |
Why?
| | Cause of Death | 1 | 2025 | 471 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.040 |
Why?
| | Muscle Hypotonia | 1 | 2021 | 34 | 0.040 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 25 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2025 | 911 | 0.040 |
Why?
| | Language Development Disorders | 1 | 2021 | 41 | 0.040 |
Why?
| | Patient Acuity | 1 | 2021 | 48 | 0.040 |
Why?
| | Workflow | 1 | 2023 | 183 | 0.040 |
Why?
| | Neuroglia | 1 | 2022 | 174 | 0.040 |
Why?
| | Face | 1 | 2023 | 175 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 442 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 372 | 0.040 |
Why?
| | Hepatocytes | 1 | 2022 | 224 | 0.040 |
Why?
| | Homocysteine | 1 | 2021 | 152 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 648 | 0.040 |
Why?
| | Methylation | 1 | 2021 | 242 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 50 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 498 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 172 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 251 | 0.040 |
Why?
| | Acyl-CoA Dehydrogenase | 1 | 2020 | 8 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2020 | 31 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2020 | 17 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2064 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 2000 | 0.040 |
Why?
| | Protein Stability | 1 | 2020 | 176 | 0.040 |
Why?
| | Facies | 1 | 2019 | 22 | 0.040 |
Why?
| | Cell Nucleolus | 1 | 2019 | 20 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 184 | 0.040 |
Why?
| | Drugs, Investigational | 1 | 2019 | 31 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 468 | 0.040 |
Why?
| | Heme | 1 | 2020 | 90 | 0.040 |
Why?
| | Phosphates | 1 | 2020 | 177 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 104 | 0.040 |
Why?
| | Feeding and Eating Disorders | 1 | 2021 | 165 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2022 | 429 | 0.040 |
Why?
| | 14-3-3 Proteins | 1 | 2018 | 15 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2019 | 104 | 0.040 |
Why?
| | Leukemia | 1 | 2021 | 246 | 0.040 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 24 | 0.040 |
Why?
| | Aneuploidy | 1 | 2019 | 91 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 227 | 0.040 |
Why?
| | Brain Diseases | 1 | 2020 | 155 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2018 | 25 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 178 | 0.030 |
Why?
| | Drug Discovery | 1 | 2019 | 153 | 0.030 |
Why?
| | Nutritional Status | 1 | 2021 | 353 | 0.030 |
Why?
| | Risk Factors | 1 | 2013 | 10916 | 0.030 |
Why?
| | Oocytes | 1 | 2019 | 185 | 0.030 |
Why?
| | Dermis | 1 | 2018 | 31 | 0.030 |
Why?
| | Critical Illness | 1 | 2024 | 900 | 0.030 |
Why?
| | Weight Gain | 1 | 2021 | 561 | 0.030 |
Why?
| | Aminoacylation | 1 | 2017 | 14 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 532 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1676 | 0.030 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2017 | 32 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2018 | 194 | 0.030 |
Why?
| | Iron-Sulfur Proteins | 1 | 2018 | 47 | 0.030 |
Why?
| | Metabolomics | 1 | 2023 | 733 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 300 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2933 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 11793 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 831 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1568 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1068 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 707 | 0.030 |
Why?
| | Electroencephalography | 1 | 2019 | 563 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2131 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 1048 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1652 | 0.030 |
Why?
| | Family | 1 | 2020 | 684 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 553 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 273 | 0.030 |
Why?
| | Caregivers | 1 | 2023 | 1073 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2024 | 5428 | 0.030 |
Why?
| | Child Development | 1 | 2019 | 483 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 719 | 0.030 |
Why?
| | DNA Methylation | 1 | 2019 | 690 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2018 | 414 | 0.030 |
Why?
| | Mice | 2 | 2023 | 18357 | 0.020 |
Why?
| | Liver | 1 | 2022 | 1899 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2018 | 574 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2014 | 153 | 0.020 |
Why?
| | Prognosis | 1 | 2021 | 4329 | 0.020 |
Why?
| | Kidney Transplantation | 1 | 2018 | 712 | 0.020 |
Why?
| | Kidney | 1 | 2018 | 1498 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4151 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2770 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 3118 | 0.020 |
Why?
|
|
Larson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|